| From fatty liver to fibrosis: a tale of “second hit” M Basaranoglu, G Basaranoglu, H Sentürk World journal of gastroenterology: WJG 19 (8), 1158, 2013 | 222 | 2013 |
| Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. V Tahan, B Canbakan, H Balci, F Dane, H Akin, G Can, I Hatemi, V Olgac, ... Hepato-gastroenterology 55 (85), 1433-1438, 2008 | 155 | 2008 |
| Melatonin reduces dimethylnitrosamine‐induced liver fibrosis in rats V Tahan, R Ozaras, B Canbakan, H Uzun, S Aydin, B Yildirim, H Aytekin, ... Journal of pineal research 37 (2), 78-84, 2004 | 108 | 2004 |
| Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease E Köroğlu, B Canbakan, K Atay, İ Hatemi, M Tuncer, A Dobrucalı, ... Turk J Gastroenterol 27 (4), 361-6, 2016 | 83 | 2016 |
| Leptin in nonalcoholic fatty liver disease B Canbakan, V Tahan, H Balci, I Hatemi, B Erer, G Ozbay, N Sut, ... Annals of hepatology 7 (3), 249-254, 2008 | 79 | 2008 |
| Efficacy of interferon α‐2b and lamivudine combination treatment in comparison to interferon α‐2b alone in chronic delta hepatitis: A randomized trial B Canbakan, H Senturk, F Tabak, M Akdogan, V Tahan, A Mert, N Sut, ... Journal of gastroenterology and hepatology 21 (4), 657-663, 2006 | 59 | 2006 |
| Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers H Senturk, V Tahan, B Canbakan, S Uraz, Y Ulger, R Ozaras, F Tabak, ... Neth J Med 66 (5), 191-5, 2008 | 43 | 2008 |
| Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease B Canbakan, H Senturk, V Tahan, I Hatemi, H Balci, T Toptas, A Sonsuz, ... Acta Gastro-Enterol. Belgica 70, 277-284, 2007 | 43 | 2007 |
| Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? B Canbakan, H Senturk, M Canbakan, T Toptas, O Tabak, H Balci, ... Biomarkers in medicine 4 (2), 205-214, 2010 | 38 | 2010 |
| Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis B, C and delta infections H Senturk, V Tahan, B Canbakan, F Dane, Y Ulger, R Ozaras, F Tabak, ... Annals of Hepatology 7 (1), 52-58, 2008 | 32 | 2008 |
| Carbamazepine-induced hypogammaglobulinemia N Ozaras, N Goksugur, S Eroglu, O Tabak, B Canbakan, R Ozaras Seizure 21 (3), 229-231, 2012 | 27 | 2012 |
| Cytomegalovirus infection of gastrointestinal tract with multiple ulcers and strictures, causing obstruction in a patient with common variable immunodeficiency syndrome V Tahan, A Dobrucali, B Canbakan, I Hamzaoglu, R Ozaras, M Biyikli, ... Dig Dis Sci 45 (9), 1781-85, 2000 | 25 | 2000 |
| Karaciğer enzim yüksekliklerine klinik yaklaşım H Şentürk, B Canbakan, İ Hatemi İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi …, 2004 | 22 | 2004 |
| Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C M Canbakan, H Senturk, B Canbakan, T Toptas, O Tabak, R Ozaras, ... Nephron Clinical Practice 117 (3), c289-c295, 2011 | 21 | 2011 |
| Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection H Senturk, B Baysal, V Tahan, H Zerdali, R Ozaras, F Tabak, A Mert, ... Digestive diseases and sciences 56, 208-212, 2011 | 20 | 2011 |
| Efficacy of pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection H Senturk, F Tabak, R Ozaras, L Erdem, B Canbakan, A Mert, I Yurdakul Digestive diseases and sciences 54, 2026-2030, 2009 | 19 | 2009 |
| Apoptosis and disease severity is associated with insulin resistance in non-alcoholic fatty liver disease K Atay, B Canbakan, E Koroglu, I Hatemi, M Canbakan, N Kepil, M Tuncer, ... Acta gastro-enterologica belgica 80 (2), 271-277, 2017 | 16 | 2017 |
| Liver steatosis in hepatitis C positive hemodialysis patients and factors affecting IFN-2a treatment B Yildirim, H Durak, R Ozaras, B Canbakan, P Ozkan, G Ozbay, H Senturk Scandinavian journal of gastroenterology 41 (10), 1235-1241, 2006 | 11 | 2006 |
| The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats B Canbakan, H Akin, G Tahan, O Tarcin, F Eren, O Atug, V Tahan, ... Annals of hepatology 8 (3), 234-240, 2009 | 10 | 2009 |
| Blindness as a complication of hepatic encephalopathy B Canbakan, M Canbakan, V Oz, M Tuncer, M Demir Wiener Medizinische Wochenschrift (1946) 151 (18-20), 477-480, 2001 | 10 | 2001 |
